HUGO BOSS AG:企業の戦略・SWOT・財務情報

◆英語タイトル:HUGO BOSS AG - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C2174
◆発行会社(調査会社):MarketLine
◆発行日:2018年7月
◆ページ数:41
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:小売り
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

HUGO BOSS AG – Strategy, SWOT and Corporate Finance Report
Summary

HUGO BOSS AG – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

HUGO BOSS AG (HUGO BOSS or ‘the company’) is a German-based company engaged in the manufacturing and sale of premium and luxury fashion and accessories for men and women under the BOSS, BOSS Orange, BOSS Green and HUGO brand names. It offers sportswear, modern apparel, eveningwear, casualwear, shoes, leather accessories, licensed fragrances, watches, eyewear, writing instruments and home textiles. The company also operates online stores in Germany, the UK, France, Spain, Italy, Netherlands, Belgium, Austria, Switzerland, the US and China. The company has its operations across Europe, the Americas, and Asia/Pacific. HUGO BOSS is headquartered in Metzingen, Germany.

Scope

- Detailed information on HUGO BOSS AG required for business and competitor intelligence needs
- A study of the major internal and external factors affecting HUGO BOSS AG in the form of a SWOT analysis
- An in-depth view of the business model of HUGO BOSS AG including a breakdown and examination of key business segments
- Intelligence on HUGO BOSS AG’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about HUGO BOSS AG, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of HUGO BOSS AG and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess HUGO BOSS AG as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on HUGO BOSS AG’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 5
HUGO BOSS AG: Company Overview 9
HUGO BOSS AG: Overview and Key Facts 9
HUGO BOSS AG: Overview 9
HUGO BOSS AG: Key Facts 9
HUGO BOSS AG: Key Employees 10
HUGO BOSS AG: Key Employee Biographies 11
HUGO BOSS AG: Major Products and Services 16
HUGO BOSS AG: Company History 17
HUGO BOSS AG: Management Statement 20
HUGO BOSS AG: Locations and Subsidiaries 22
HUGO BOSS AG: Key Competitors 23
HUGO BOSS AG: Company Analysis 24
HUGO BOSS AG: Business Description 24
HUGO BOSS AG: SWOT Analysis 26
HUGO BOSS AG: SWOT Overview 26
HUGO BOSS AG: Strengths 26
HUGO BOSS AG: Weaknesses 27
HUGO BOSS AG: Opportunities 28
HUGO BOSS AG: Threats 29
HUGO BOSS AG: Corporate Financial Deals Activity 30
HUGO BOSS AG: Financial Deals Overview 30
HUGO BOSS AG: Top Deals 2014 – 2018YTD* 31
HUGO BOSS AG: Capital Raising 32
HUGO BOSS AG: Private Equity and Ownership 33
HUGO BOSS AG: Recent Developments 34
HUGO BOSS AG: News and Events Summary 34
HUGO BOSS AG: Business Expansion 35
HUGO BOSS AG: Corporate Governance 35
HUGO BOSS AG: Financial Deals 36
HUGO BOSS AG: Financial Performance 36
HUGO BOSS AG: Strategy and Operations 37
Appendix 39
Contact Us 39
Methodology 39
About MarketLine 40

List of Tables
Table 1: HUGO BOSS AG: Key Facts
Table 2: HUGO BOSS AG: Key Employees
Table 3: HUGO BOSS AG: Locations and Subsidiaries
Table 4: HUGO BOSS AG: Key Competitors
Table 5: HUGO BOSS AG: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 6: HUGO BOSS AG: Top Deals 2014 - 2018YTD*
Table 7: HUGO BOSS AG: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Table 8: HUGO BOSS AG: Capital Raising by Deal Type (2014 - YTD*2018)
Table 9: HUGO BOSS AG: Private Equity and Ownership Volume and Value Trend (2014 - YTD*2018)
Table 10: HUGO BOSS AG: Private Equity and Ownership Volume by Deal Type (2014 - YTD*2018)
Table 11: HUGO BOSS AG: News and Events Summary
Table 12: HUGO BOSS AG: Business Expansion
Table 13: HUGO BOSS AG: Corporate Governance
Table 14: HUGO BOSS AG: Financial Deals
Table 15: HUGO BOSS AG: Financial Performance
Table 16: HUGO BOSS AG: Strategy and Operations

List of Figures
Figure 1: HUGO BOSS AG: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 2: HUGO BOSS AG: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Figure 3: HUGO BOSS AG: Capital Raising by Deal Type (2014 - YTD*2018)
Figure 4: HUGO BOSS AG: Private Equity and Ownership Volume and Value Trend (2014 - YTD*2018)
Figure 5: HUGO BOSS AG: Private Equity and Ownership Volume by Deal Type (2014 - YTD*2018)

★海外企業調査レポート[HUGO BOSS AG:企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Unicharm Corporation (8113):企業の財務・戦略的SWOT分析
    Unicharm Corporation (8113) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • R Pharm-製薬・医療分野:企業M&A・提携分析
    Summary R Pharm is a pharmaceutical company that offers drug development and manufacturing. The company offers finished dosage forms, active pharmaceutical ingredients (api) and biotechnological substances. It provides products in therapeutic areas of oncology, hematology, immune diseases, antibioti …
  • Luye Pharma Group Ltd (2186):企業の財務・戦略的SWOT分析
    Summary Luye Pharma Group Ltd (Luye Pharma Group) is a drug company that manufactures, develops, discovers, and commercializes novel formulations, natural drugs, medicinal products, pharmaceutical products, and biotechnology products. The group’s products include paclitaxel liposome, lentinan, sodiu …
  • EyeGate Pharmaceuticals Inc (EYEG):企業の財務・戦略的SWOT分析
    Summary EyeGate Pharmaceuticals Inc (EyeGate) is a clinical-stage specialty pharmaceutical and drug delivery company that develops and commercializes products for treating diseases and disorders of the eye. The company’s proprietary technology EyeGate II delivery system, utilizes transscleral iontop …
  • S&T Dynamics Co., Ltd.:企業の戦略・SWOT・財務情報
    S&T Dynamics Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary S&T Dynamics Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Bharat Heavy Electricals Ltd (BHEL)-エネルギー分野:企業M&A・提携分析
    Summary Bharat Heavy Electricals Limited (BHEL) is an integrated power plant equipment manufacturer that designs, manufactures, constructs, tests, commissions and services a broad range of products. Its product portfolio includes transformers, valves and oil field equipment, electrostatic precipitat …
  • EBN B.V.:石油・ガス:M&Aディール及び事業提携情報
    Summary EBN BV (EBN) is an independent oil and natural gas company that carries out exploration, production, storage and trading of oil and natural gas. The company participates in nearly all the exploration and production activities in the Netherlands through a public-private partnership model. It …
  • Telecom Italia S.p.A.:企業の戦略・SWOT・財務情報
    Telecom Italia S.p.A. - Strategy, SWOT and Corporate Finance Report Summary Telecom Italia S.p.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Caladrius Biosciences Inc (CLBS):企業の財務・戦略的SWOT分析
    Summary Caladrius Biosciences Inc (Caladrius), formerly NeoStem Inc, is a clinical-stage biopharmaceutical company that develops cell therapy products. The company offers multiple technology platforms targeting cardiovascular indications and autoimmune diseases. The company’s lead product CLBS03 is …
  • U.S. Stem Cell Inc (USRM):製薬・医療:M&Aディール及び事業提携情報
    Summary U.S. Stem Cell Inc (U.S. Stem Cell), formerly Bioheart, Inc, is a biotechnology company that focuses on the discovery, development and commercialization of cell based therapeutics products. The company repairs and replaces damaged or aged tissue, cells and organs and restoring their normal f …
  • Logan Resources Ltd:企業の戦略・SWOT・財務情報
    Logan Resources Ltd - Strategy, SWOT and Corporate Finance Report Summary Logan Resources Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Siemens Healthineers.:企業の戦略・SWOT・財務情報
    Siemens Healthineers. - Strategy, SWOT and Corporate Finance Report Summary Siemens Healthineers. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Public Financial Holdings Limited (626):企業の財務・戦略的SWOT分析
    Public Financial Holdings Limited (626) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Genetic Signatures Ltd (GSS):医療機器:M&Aディール及び事業提携情報
    Summary Genetic Signatures Ltd (Genetic Signatures), formerly Human Genetic Signatures Pty Ltd, is a molecular diagnostics company. The company designs and manufactures real-time polymerase chain reaction (PCR) based products for the detection of infectious diseases under the EasyScreen brand. It of …
  • 3M India Limited (3MINDIA):企業の財務・戦略的SWOT分析
    3M India Limited (3MINDIA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Herman Miller Inc (MLHR):企業の財務・戦略的SWOT分析
    Herman Miller Inc (MLHR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • China Sunshine Paper Holdings Company Limited:戦略・SWOT・企業財務分析
    China Sunshine Paper Holdings Company Limited - Strategy, SWOT and Corporate Finance Report Summary China Sunshine Paper Holdings Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, opera …
  • Keppel Corporation Limited:企業の戦略・SWOT・財務情報
    Keppel Corporation Limited - Strategy, SWOT and Corporate Finance Report Summary Keppel Corporation Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Xactware Solutions Inc:企業の戦略的SWOT分析
    Xactware Solutions Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Heat Biologics Inc (HTBX):企業の財務・戦略的SWOT分析
    Heat Biologics Inc (HTBX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆